JAK Inhibitors in Rheumatoid Arthritis: Overcoming Challenges and Maximizing Impact Podcast Por  arte de portada

JAK Inhibitors in Rheumatoid Arthritis: Overcoming Challenges and Maximizing Impact

JAK Inhibitors in Rheumatoid Arthritis: Overcoming Challenges and Maximizing Impact

Escúchala gratis

Ver detalles del espectáculo

Obtén 3 meses por US$0.99 al mes

See where Janus kinase (JAK) inhibitors fit into rheumatoid arthritis (RA) treatment to tackle obstacles and improve patient outcomes.

Credit available for this activity expires: 12/10/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/[articleID]?ecd=bdc_podcast_libsyn_mscpedu

Todavía no hay opiniones